Guj. Terce Labs.

31
Sell
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE499G01013
  • NSEID:
  • BSEID: 524314
INR
37.10
-0.24 (-0.64%)
BSENSE

Aug 11, 03:30 PM

BSE+NSE Vol: 13.52 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2026 is -5.42% vs 4.63% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2026 is -3.47% vs 206.50% in Mar 2025

stock-summary

Interest

YoY Growth in year ended Mar 2026 is -56.79% vs -38.55% in Mar 2025

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2026 is 324.98% vs -501.89% in Mar 2025

Compare Profit and Loss Results of Guj. Terce Labs.
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
47.00
37.00
10.00
27.03%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
47.00
37.00
10.00
27.03%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0%
Raw Materials Consumed
17.00
22.00
-5.00
-22.73%
Power & Fuel Cost
0.00
0.00
0.00
0%
Employee Cost
16.00
3.00
13.00
433.33%
Operating Expenses
0.00
2.00
-2.00
-100.00%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
3.00
0.00
3.00
0%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
1.00
-1.00
-100.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
43.00
31.00
12.00
38.71%
Operating Profit (PBDIT) excl Other Income
3.00
5.00
-2.00
-40.00%
Other Income
0.00
0.00
0.00
0%
Operating Profit (PBDIT)
4.00
5.00
-1.00
-20.00%
Interest
0.00
0.00
0.00
0%
Profit before Depriciation and Tax
3.00
5.00
-2.00
-40.00%
Depreciation
0.00
0.00
0.00
0%
Profit Before Taxation & Exceptional Items
3.00
4.00
-1.00
-25.00%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
3.00
4.00
-1.00
-25.00%
Provision for Tax
0.00
1.00
-1.00
-100.00%
Profit After Tax
2.00
3.00
-1.00
-33.33%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
-3.00
4.00
-7.00
-175.00%
Profit Available for appropriations
-1.00
7.00
-8.00
-114.29%
Appropriations
-1.00
7.00
-8.00
-114.29%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
2.92
2.98
-0.06
-2.01%
Profit And Loss - Net Sales
Net Sales 47.47 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is -5.42% vs 4.63% in Mar 2025

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 3.75 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is -3.47% vs 206.50% in Mar 2025

Profit And Loss - Interest
Interest 0.18 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is -56.79% vs -38.55% in Mar 2025

Profit And Loss - Profit After Tax
Profit After Tax 2.20 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 324.98% vs -501.89% in Mar 2025